Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection.
In: Structure (London, England : 1993), Jg. 30 (2022-09-01), Heft 9, S. 1224-1232.e5
academicJournal
Zugriff:
Emerging new variants of SARS-CoV-2 and inevitable acquired drug resistance call for the continued search of new pharmacological targets to fight the potentially fatal infection. Here, we describe the mechanisms by which the E protein of SARS-CoV-2 hijacks the human transcriptional regulator BRD4. We found that SARS-CoV-2 E is acetylated in vivo and co-immunoprecipitates with BRD4 in human cells. Bromodomains (BDs) of BRD4 bind to the C-terminus of the E protein, acetylated by human acetyltransferase p300, whereas the ET domain of BRD4 recognizes the unmodified motif of the E protein. Inhibitors of BRD4 BDs, JQ1 or OTX015, decrease SARS-CoV-2 infectivity in lung bronchial epithelial cells, indicating that the acetyllysine binding function of BDs is necessary for the virus fitness and that BRD4 represents a potential anti-COVID-19 target. Our findings provide insight into molecular mechanisms that contribute to SARS-CoV-2 pathogenesis and shed light on a new strategy to block SARS-CoV-2 infection.
Competing Interests: Declaration of interests The authors declare no competing interests.
(Copyright © 2022 Elsevier Ltd. All rights reserved.)
Titel: |
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection.
|
---|---|
Autor/in / Beteiligte Person: | Vann, KR ; Acharya, A ; Jang, SM ; Lachance, C ; Zandian, M ; Holt, TA ; Smith, AL ; Pandey, K ; Durden, DL ; El-Gamal, D ; Côté, J ; Byrareddy, SN ; Kutateladze, TG |
Zeitschrift: | Structure (London, England : 1993), Jg. 30 (2022-09-01), Heft 9, S. 1224-1232.e5 |
Veröffentlichung: | 2000- : Cambridge, Mass. : Cell Press ; <i>Original Publication</i>: London : Current Biology, c1993-, 2022 |
Medientyp: | academicJournal |
ISSN: | 1878-4186 (electronic) |
DOI: | 10.1016/j.str.2022.05.020 |
Schlagwort: |
|
Sonstiges: |
|